Translating bioinformatics in oncology: Guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis

Bioinformatics

Volumn 31, Issue 2, 2015, Pages 216-224

  Itzel, Timo ^a   Scholz, Peter ^b   Maass, Thorsten ^a   Krupp, Markus ^b   Marquardt, Jens U ^b   Strand, Susanne ^b   Becker, Diana ^b   Staib, Frank ^b   Binder, Harald ^c   Roessler, Stephanie ^d   Wang, Xin Wei ^e   Thorgeirsson, Snorri ^e   Müller, Martina ^a   Galle, Peter R ^b   Teufel, Andreas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDCA3 PROTEIN, HUMAN; CELL CYCLE PROTEIN; KIF18B PROTEIN, HUMAN; KINESIN; TUMOR MARKER;

BIOLOGY; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; DISEASE COURSE; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MORTALITY; NEOPLASM; PATHOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR STEM CELL ASSAY; WESTERN BLOTTING;

BIOMARKERS, TUMOR; BLOTTING, WESTERN; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINESIN; LIVER NEOPLASMS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84928986825     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu586     Document Type: Article

References (40)

1. Andersen, J.B. et al. (2009) Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology, 51, 1401-1409.
2. Baehner, F.L. et al. (2011) Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy. J. Surg. Oncol., 103, 563-573.
3. Barrett, T. et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res., 41, D991-D995.
4. Becker, K.G. et al. (2003) PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics, 4, 61.
5. Bucher, N. and Britten, C.D. (2008) G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br. J. Cancer, 98, 523-528.
6. Cahanm, P. et al. (2007) Meta-Analysis of microarray results: challenges, opportunities, and recommendations for standardization. Gene, 401, 12-18.
7. Charrad, M. et al. (2010) On the Number of Clusters in Block Clustering Algorithms. Proceedings of the Twenty-Third International Florida Artificial Intelligence Research Society Conference, 2010.
8. Cheadle, C. et al. (2003) Analysis of microarray data using Z score transformation. J. Mol. Diagn., 5, 73-81.
9. Date, S.V. et al. (2003) Discovery of uncharacterized cellular systems by genome-wide analysis of functional linkages. Nat. Biotechnol., 21, 1055-1062.
10. Davis, S. et al. (2007) GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics, 23, 1846-1847.
11. Eisen, M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95, 14863-14868.
12. Garcia-Fernandez, R.A. et al. (2011) Combined loss of p21(waf1/cip1) and p27(kip1) enhances tumorigenesis in mice. Lab. Invest., 91, 1634-1642.
13. Hawkes, W.C. and Alkan, Z. (2011) Delayed cell cycle progression from SEPW1 depletion is p53-And p21-dependent in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun., 413, 36-40.
14. Hughes, T.R. et al. (2000) Functional discovery via a compendium of expression profiles. Cell, 102, 109-126.
15. Ioannidis, J.P. (2010) Expectations, validity, and reality in omics. J. Clin. Epidemiol., 63, 945-949.
16. Jemal, A. et al. (2009) Cancer statistics. CA Cancer J. Clin., 59, 225-249.
17. Jia, L. et al. (2009) ROC1/RBX1 E3 ubiquitin ligase silencing suppresses tumor cell growth via sequential induction of G2-M arrest, apoptosis, and senescence. Cancer Res., 69, 4974-4982.
18. Krupp, M. et al. (2011) The functional cancer map: a systems-level synopsis of genetic deregulation in cancer. BMC Med. Genomics, 4, 53.
19. Laiho, M. and Latonen, L. (2003) Cell cycle control, DNA damage checkpoints and cancer. Ann. Med., 35, 391-397.
20. Lee, E.Y. and Muller, W.J. (2010) Oncogenes and Tumor Suppressor Genes. Cold Spring Harb Perspect Biol. 2: a003236, 2010.
21. Lee, H.K. et al. (2004) Coexpression analysis of human genes across many micro-Array data sets. Genome Res., 14, 1085-1094.
22. Hishigaki, H. et al. (2001) Assessment of prediction accuracy of protein function from protein-protein interaction data. Yeast, 18, 523-531.
23. Kim, J.K. et al. (2009) Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Int. J. Oncol., 35, 1257-1264.
24. Marquardt, J.U. et al. (2012) Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J. Hepatol., 56, 267-275.
25. Oliver, S. (2000) Guilt-by-Association goes global. Nature, 403, 601-603.
26. Parkinson, H. et al. (2011) ArrayExpress update-An archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res., 39, D1002-D1004.
27. Pena-Castillo, L. et al. (2008) A critical assessment of Mus musculus gene function prediction using integrated genomic evidence. Genome Biol., 9 (Suppl. 1), S2.
28. Rensen, W.M. et al. (2008) The GTPase Ran: regulation of cell life and potential roles in cell transformation. Front. Biosci., 13, 4097-4121.
29. Rivadeneira, D.B. et al. (2010) Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology, 138, 1920-1930.
30. Roessler, S. et al. (2010) A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res., 70, 10202-10212.
31. Sherlock, G. et al. (2001) The Stanford microarray database. Nucleic Acids Res., 29, 152-155.
32. Sayers, E.W. et al. (2012) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res., 40, D13-D25.
33. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
34. Shimokawa, K. et al. (2010) iCOD: an integrated clinical omics database based on the systems-pathology view of disease. BMC Genomics, 11 (Suppl. 4), S19.
35. Stolovitzky, G. (2003) Gene selection in microarray data: the elephant, the blind men and our algorithms. Curr. Opin. Struct. Biol., 13, 370-376.
36. Takeuchi, M. et al. (1996) Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem., 271, 19935-19942.
37. Teufel, A. et al. (2012) Novel insights in the genetics of HCC recurrence and advances in transcriptomic data integration. J. Hepatol., 56, 279-281.
38. Tsuda, K. et al. (2005) Fast protein classification with multiple networks. Bioinformatics, 21 (Suppl. 2), ii59-ii65.
39. Wolfe, C.J. (2005) Systematic survey reveals general applicability of "guilt-by-Association" within gene coexpression networks. BMC Bioinformatics, 6, 227.
40. Wu, L.F. et al. (2002) Large-scale prediction of Saccharomyces cerevisiae gene function using overlapping transcriptional clusters. Nat. Genet., 31, 255-265.